David Sekula
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Biochemistry top 10%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Ubiquitin and proteasome pathways 12
- Retinoids in leukemia and cellular processes 12
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 3
- Hedgehog Signaling Pathway Studies 3
- Oncology 12
- Cancer-related Molecular Pathways 11
- Co-authors
- Ethan Dmitrovsky (26 shared papers)Sarah J. Freemantle (20 shared papers)John Langenfeld (2 shared papers)Michael J. Spinella (5 shared papers)Jay Boyle (1 shared paper)Hiroaki Kiyokawa (1 shared paper)Konstantin H. Dragnev (7 shared papers)Qing Feng (6 shared papers)
- Journals
- Cancer Research (6 papers)Molecular Cancer Therapeutics (4 papers)Oncogene (3 papers)International Journal of Oncology (2 papers)Cancer Biology & Therapy (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Sekula
26 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Oncology 387
- Biochemistry 76
- Molecular Biology 820
- Cancer Research 148
- Immunology 207
Countries citing papers authored by David Sekula
This map shows the geographic impact of David Sekula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sekula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sekula more than expected).
Fields of papers citing papers by David Sekula
This network shows the impact of papers produced by David Sekula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sekula. The network helps show where David Sekula may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sekula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 176 | |
| 2 | 1999 | 144 | |
| 3 | 2002 | 94 | |
| 4 | 1999 | 88 | |
| 5 | Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. | 2002 | 87 |
| 6 | 2008 | 75 | |
| 7 | 2010 | 54 | |
| 8 | 2004 | 54 | |
| 9 | 2001 | 48 | |
| 10 | 2016 | 43 | |
| 11 | 2016 | 38 | |
| 12 | 2012 | 37 | |
| 13 | 2007 | 36 | |
| 14 | 2014 | 32 | |
| 15 | 1998 | 32 | |
| 16 | 2005 | 29 | |
| 17 | 2007 | 29 | |
| 18 | 2015 | 18 | |
| 19 | 2015 | 17 | |
| 20 | 2012 | 16 |
About David Sekula
David Sekula is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Hematology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (12 papers), Retinoids in leukemia and cellular processes (12 papers), Cancer-related Molecular Pathways (11 papers), interferon and immune responses (4 papers), Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (3 papers), Microtubule and mitosis dynamics (3 papers) and Hedgehog Signaling Pathway Studies (3 papers). The work is most often cited by research in Oncology (387 citations), Biochemistry (76 citations), Molecular Biology (820 citations), Cancer Research (148 citations) and Immunology (207 citations). David Sekula has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ethan Dmitrovsky, Sarah J. Freemantle, John Langenfeld, Michael J. Spinella, Jay Boyle, Hiroaki Kiyokawa, Konstantin H. Dragnev, Qing Feng, Sutisak Kitareewan and Fulvio Lonardo. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Oncogene, International Journal of Oncology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.